AI-native health hardware company Shanmu has secured nearly 100 million yuan in Series A funding, led by Shixi Capital and including participation from existing investors. The company plans to use these funds to launch its direct-to-consumer medical products, fulfill B2B custom module deliveries, and pursue international medical certifications. Shanmu's innovative approach involves embedding medical-grade devices into daily life, such as a toilet-mounted analyzer that continuously collects urine, saliva, and sweat samples for AI-driven health monitoring and intervention. AI
影响 This funding round and product development could accelerate the integration of AI-driven continuous health monitoring into daily life, shifting focus from reactive treatment to proactive health management.
排序理由 AI-native health hardware company Shanmu secured nearly 100 million yuan in Series A funding. [lever_c_demoted from significant: ic=1 ai=0.7]
- Bojiang Capital
- Gan Jie
- Gao Bingqiang
- Gengxin Capital
- ICANX Fund
- Lin Hequan
- Peking University
- Qifu Capital
- Shanghai Angel Society
- Shixi Capital
- Shuoyin Technology
- Songhe Capital
- FDA
- Wanwuwei Capital
- Yonghua Investment
- Zhaoyi Innovation
- Zhihang No. 1 Fund
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
